Wiggans Thomas G

Former Director at ANNX; CEO & Chairman of the Board at Dermira, Inc.; Director at ONYX PHARMACEUTICALS INC, and 2 more

Sold, on record
$8.3M
Dollars the filings state
Form 4 sales
34
Latest Dec 13, 2017
Form 144 notices
3
Proposed sales
Companies
5
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale Dermira, Inc.Plan not stated
    Aug 1, 2017 2017

    Sold 500 shares at $27.58 ($14k)

    Wiggans Thomas G, CEO & Chairman of the Board

    Sold 6.1% of holdings ($226k position)7,690 shares left0.1x usual sizeFiling

  2. 2 Form 4 sale Dermira, Inc.Unusual
    Sep 18, 2017 +48 days

    Sold 9,500 shares at $27.51 ($261k)

    Wiggans Thomas G, CEO & Chairman of the Board

    Sold 41.4% of holdings ($631k position)13,427 shares left1.1x usual sizeFiling

  3. 3 Form 4 sale Dermira, Inc.Unusual
    Oct 10, 2017 +22 days

    Sold 5,000 shares at $27.52 ($138k)

    Wiggans Thomas G, CEO & Chairman of the Board

    Sold 27.1% of holdings ($507k position)13,427 shares left0.6x usual sizeFiling

  4. 4 Form 4 sale Dermira, Inc.Unusual
    Nov 2, 2017 +23 days

    Sold 5,000 shares at $27.52 ($138k)

    Wiggans Thomas G, CEO & Chairman of the Board

    Sold 27.1% of holdings ($507k position)13,427 shares left0.6x usual sizeFiling

  5. 5 Form 4 sale Dermira, Inc.Unusual
    Dec 13, 2017 +41 days

    Sold 5,000 shares at $27.51 ($138k)

    Wiggans Thomas G, CEO & Chairman of the Board

    Sold 26.8% of holdings ($513k position)13,662 shares left0.6x usual sizeFiling

  6. 6 Form 144 notice ANNXNotice
    Jul 14, 2026 +3135 days

    Filed to sell 1,000 shares ($6k)

    Wiggans Thomas G, Former Director

    No 10b5-1 planFirst sale on recordFiling

  7. 7 Form 144 notice ANNXNotice
    Jul 15, 2026 +1 day

    Filed to sell 2,000 shares ($13k)

    Wiggans Thomas G, Former Director

    No 10b5-1 planFirst sale on recordFiling

  8. 8 Form 144 notice ANNXNotice
    Aug 13, 2026 +29 days

    Filed to sell 2,000 shares ($11k)

    Wiggans Thomas G, Former Director

    No 10b5-1 planFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (37)

Form 144 notices and Form 4 sales by Wiggans Thomas G
Source
Aug 13, 2026Aug 13, 2026ANNXFormer DirectorForm 144 notice2,000$11kNoticeSEC
Jul 15, 2026Jul 15, 2026ANNXFormer DirectorForm 144 notice2,000$13kNoticeSEC
Jul 14, 2026Jul 14, 2026ANNXFormer DirectorForm 144 notice1,000$6kNoticeSEC
Dec 13, 2017Dec 15, 2017Dermira, Inc.CEO & Chairman of the BoardForm 4 sale5,000$138k26.8%UnusualSEC
Nov 2, 2017Nov 3, 2017Dermira, Inc.CEO & Chairman of the BoardForm 4 sale5,000$138k27.1%UnusualSEC
Oct 10, 2017Oct 11, 2017Dermira, Inc.CEO & Chairman of the BoardForm 4 sale5,000$138k27.1%UnusualSEC
Sep 18, 2017Sep 19, 2017Dermira, Inc.CEO & Chairman of the BoardForm 4 sale9,500$261k41.4%UnusualSEC
Aug 1, 2017Aug 2, 2017Dermira, Inc.CEO & Chairman of the BoardForm 4 sale500$14k6.1%Plan not statedSEC
Jul 3, 2017Jul 5, 2017Dermira, Inc.CEO & Chairman of the BoardForm 4 sale5,000$145k39.4%UnusualSEC
Jun 2, 2017Jun 5, 2017Dermira, Inc.CEO & Chairman of the BoardForm 4 sale5,000$138k39.4%UnusualSEC
May 1, 2017May 3, 2017Dermira, Inc.CEO & Chairman of the BoardForm 4 sale8,000$269k55.3%UnusualSEC
Apr 3, 2017Apr 4, 2017Dermira, Inc.CEO & Chairman of the BoardForm 4 sale8,000$268k55.3%UnusualSEC
Mar 3, 2017Mar 7, 2017Dermira, Inc.CEO & Chairman of the BoardForm 4 sale4,000$150k38.2%UnusualSEC
Mar 1, 2017Mar 2, 2017Dermira, Inc.CEO & Chairman of the BoardForm 4 sale11,000$369k63.0%UnusualSEC
Feb 1, 2017Feb 3, 2017Dermira, Inc.CEO & Chairman of the BoardForm 4 sale5,000$147k43.6%UnusualSEC
Jan 4, 2017Jan 5, 2017Dermira, Inc.CEO & Chairman of the BoardForm 4 sale8,000$248k55.3%UnusualSEC
Dec 1, 2016Dec 2, 2016Dermira, Inc.CEO & Chairman of the BoardForm 4 sale11,000$339k7.6%Plan not statedSEC
Nov 1, 2016Nov 2, 2016Dermira, Inc.CEO & Chairman of the BoardForm 4 sale11,000$343k7.0%Plan not statedSEC
Oct 3, 2016Oct 4, 2016Dermira, Inc.CEO & Chairman of the BoardForm 4 sale11,000$381k6.6%Plan not statedSEC
Sep 1, 2016Sep 2, 2016Dermira, Inc.CEO & Chairman of the BoardForm 4 sale11,000$348k6.2%Plan not statedSEC
Aug 1, 2016Aug 3, 2016Dermira, Inc.CEO & Chairman of the BoardForm 4 sale11,000$365k5.7%Plan not statedSEC
Jul 5, 2016Jul 6, 2016Dermira, Inc.CEO & Chairman of the BoardForm 4 sale11,000$326k5.4%Plan not statedSEC
Jun 1, 2016Jun 3, 2016Dermira, Inc.CEO & Chairman of the BoardForm 4 sale11,000$347k5.1%Plan not statedSEC
May 2, 2016May 3, 2016Dermira, Inc.CEO & Chairman of the BoardForm 4 sale9,000$226k4.0%Plan not statedSEC
Apr 1, 2016Apr 5, 2016Dermira, Inc.CEO & Chairman of the BoardForm 4 sale7,000$145k3.0%Plan not statedSEC
Mar 1, 2016Mar 2, 2016Dermira, Inc.CEO & Chairman of the BoardForm 4 sale7,000$158k2.9%Plan not statedSEC
Feb 1, 2016Feb 3, 2016Dermira, Inc.CEO & Chairman of the BoardForm 4 sale9,000$245k3.6%Plan not statedSEC
Jan 4, 2016Jan 6, 2016Dermira, Inc.CEO & Chairman of the BoardForm 4 sale11,000$365k4.3%Plan not statedSEC
May 6, 2013May 8, 2013ONYX PHARMACEUTICALS INCDirectorForm 4 sale4,500$410k33.4%UnusualSEC
Apr 5, 2013Apr 9, 2013ONYX PHARMACEUTICALS INCDirectorForm 4 sale3,700$318k29.2%UnusualSEC
Mar 8, 2013Mar 11, 2013ONYX PHARMACEUTICALS INCDirectorForm 4 sale2,000$170k19.9%Plan not statedSEC
Mar 5, 2013Mar 5, 2013ONYX PHARMACEUTICALS INCDirectorForm 4 sale2,500$193k23.7%Plan not statedSEC
Feb 5, 2013Feb 6, 2013ONYX PHARMACEUTICALS INCDirectorForm 4 sale2,500$193k23.7%Plan not statedSEC
Aug 16, 2012Aug 17, 2012ONYX PHARMACEUTICALS INCDirectorForm 4 sale12,000$824k59.8%UnusualSEC
Dec 1, 2010Dec 3, 2010Somaxon Pharmaceuticals, Inc.DirectorForm 4 sale30,163$81k53.2%UnusualSEC
Mar 1, 2006Mar 3, 2006CONNETICS CORPChief Executive OfficerForm 4 sale4,000$64k1.5%Plan not statedSEC
Jan 13, 2006Jan 17, 2006CONNETICS CORPChief Executive OfficerForm 4 sale4,000$58k3.2%Plan not statedSEC